A Phase 4 interventional study of Dexamethasone and Morphine in Osteoarthritis, Knee, sponsored by University of Puerto Rico. Not yet recruiting at 1 site in Puerto Rico. Open to participants aged 24 Years and older. Per ClinicalTrials.gov, last updated 2023-09-18.
Sponsored by University of Puerto Rico · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies testing dexamethasone in Osteoarthritis, Knee — 2 open to participants now, 2 under way, none of them phase 3. Dexamethasone · Osteoarthritis, Knee.
Among the 12 studies testing dexamethasone in Osteoarthritis, Knee, this one is the 4th largest by planned enrollment, is the only one that started in 2023, is one of 9 in phase 4, and was the 7th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →2 of the 12 studies testing dexamethasone in Osteoarthritis, Knee are open now, in 2 countries. Recruiting first, the newest first:
Poznan University of Medical Sciences · Sites in Poland
Ages 60–100
By country, each count listing its studies:
Dexamethasone: first FDA approval 1958 (DECADRON), first EMA approval 2010. What it is approved for, and how studies give it, is on its page →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 24 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 1 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 90 across the 12 interventional studies. Of the 9 that completed or were terminated, 2 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 12 has an industry lead sponsor. The 7 most frequent:
University of Puerto Rico is the lead sponsor of 46 studies on the registry; 15 are open to participants now.
University of Puerto Rico has 2 studies filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
1 of the studies testing dexamethasone in Osteoarthritis, Knee that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07677215Poznan University of Medical SciencesACB and iPACK Blocks With Intravenous Dexamethasone and Perineural Dexmedetomidine in Total Knee Arthroplasty | 2027-09-01 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies testing dexamethasone in Osteoarthritis, Knee, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to evaluate the efficacy of an intravenous (IV) perioperative dexamethasone regime in the clinical outcomes after a robotic-assisted Total Knee Arthroplasty (TKA) in a Hispanic population. The study aims to propose an alternative to opioid-based pain treatment following TKA. The study hopefully validates the use of a two-dose, 8mg intravenous dexamethasone regimen for improving pain and range of motion scores in patients undergoing primary, unilateral TKA for osteoarthritis. One dose will be applied prior to incision and the other at post-operative day (POD) 1.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Dexamethasone
Drug: Morphine · Drug: Oxycodone and acetaminophen
Two 8 mg doses. One dose applied prior to incision and the other at POD1
Morphine 0.1 mg per kg intravenous every 6 hours
Drug pages: OxycodoneStudies of OxycodoneOxycodone pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · AcetaminophenStudies of AcetaminophenAcetaminophen pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
2 tabs of oral oxycodone combined with acetaminophen every 6 hours (the same pill includes both drugs)
POD 1 Visual Analogue Scale Pain Scores
Range: 0-10 (10 indicates highest degree of pain)
Time frame: Measured at 7:00AM day after surgery
POD 2 Visual Analogue Scale Pain Scores
Range: 0-10 (10 indicates highest degree of pain)
Time frame: Measured at 7:00AM two days after surgery
POD 3 Visual Analogue Scale Pain Scores
Range: 0-10 (10 indicates highest degree of pain)
Time frame: Measured at 7:00AM three days after surgery
POD 1 Range of Motion
Time frame: Measured at 7:00AM the day after surgery
POD 2 Range of Motion
Time frame: Measured at 7:00AM two days after surgery
POD 3 Range of Motion
Time frame: Measured at 7:00AM three days after surgery
Daily Dextrose Concentration (mg/dL)
Time frame: Measured at 7:00AM for 3 days after surgery
Length of Stay
Measured in days
Time frame: From hospital admission to the date of discharge (About 3 days)
Start is estimated for Sep 2023; primary completion for Feb 2024, 5 months later.
Of 88 non-industry phase 4 interventional studies under Osteoarthritis, Knee, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 32. This study's planned 5 months is below that.
Counting every sponsor, half of 97 studies reached it within 19 months; a quarter within 10 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Dexamethasone
University of Puerto Rico